Senthilnathan Palaniyandi

Author

Louisiana State University Health Sciences Center Shreveport ORCID

Also Known As

P. Senthilnathan, Palaniyandi Senthilnathan, S Palaniyandi, Senthilnathan Palaniyandi

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Louisiana State University Health Sciences Center Shreveport University of Madras National University of Singapore Loma Linda University National University Hospital

About

Senthilnathan Palaniyandi is an author at Louisiana State University Health Sciences Center Shreveport specializing in medicine, cancer research, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	727
2	Biochemistry	3	3	149
3	Health Sciences	1	1	52
4	Cell Biology	1	1	52
5	Cellular Therapies	1	1	11

Senthilnathan Palaniyandi

Publications

Citations

H-Index

Page 1

	Year	Citations
Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage Lukas Schwab, Luise Goroncy, Senthilnathan Palaniyandi, Nature Medicine InflammationGraft-versus-host DiseaseIntestinal TransplantationAutoimmune DiseaseMucosal Immunology	2014	291
Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML Jianbiao Zhou, Chonglei Bi, Jasinghe V. Janakakumara, Blood	2009	160
Therapeutic effect of paclitaxel and propolis on lipid peroxidation and antioxidant system in 7,12 dimethyl benz(a)anthracene-induced breast cancer in female Sprague Dawley rats R. Padmavathi, Senthilnathan Palaniyandi, Dechen Chodon, Life Sciences Breast OncologyTherapeutic EffectBiochemistryAnthracene-induced Breast CancerMedicine	2005	99
Enhancement of antitumor effect of paclitaxel in combination with immunomodulatory Withania somnifera on benzo(a)pyrene induced experimental lung cancer Senthilnathan Palaniyandi, R. Padmavathi, Syed Mumtaz Banu, Chemico-Biological Interactions OncologyExperimental Lung CancerMedicineBronchial NeoplasmPharmacotherapy	2005	63
Inhibition of CD44 expression in hepatocellular carcinoma cells enhances apoptosis, chemosensitivity, and reduces tumorigenesis and invasion Zhigang Xie, Lai-Fong Poon, Jianbiao Zhou, Cancer Chemotherapy and Pharmacology Tumor BiologyOncologyCd44 ExpressionHealth SciencesMedicine	2008	52
<i>In vivo</i> protective effect of crocetin on benzo(a)pyrene‐induced lung cancer in Swiss albino mice Venkatraman Magesh, Konga DurgaBhavani, Senthilnathan Palaniyandi, Phytotherapy Research	2008	49
Adenoviral delivery of Tousled kinase for the protection of salivary glands against ionizing radiation damage Senthilnathan Palaniyandi, Yoshinobu Odaka, W Green, Gene Therapy Radiation MedicineImmunologySalivary GlandsRadiation DamageTousled Kinase	2010	39
Chemotherapeutic efficacy of paclitaxel in combination with <i>Withania somnifera</i> on benzo(a)pyrene‐induced experimental lung cancer Senthilnathan Palaniyandi, R. Padmavathi, Venkatraman Magesh, Cancer Science Chemoprevention StrategyOncogenic AgentExperimental Lung CancerMedicinePharmacology	2006	37
ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft Viraj J. Jasinghe, Zhigang Xie, Jianbiao Zhou, Journal of Hepatology MedicinePharmacologyPathologyLiver CancerAnti-cancer Agent	2008	34
Therapeutic effect of propolis and paclitaxel on hepatic phase I and II enzymes and marker enzymes in dimethylbenz(a)anthracene-induced breast cancer in female rats R. Padmavathi, Senthilnathan Palaniyandi, Dhanapal Sakthisekaran Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology Breast OncologyTherapeutic EffectBiochemistryAnthracene-induced Breast CancerMedicine	2006	33

Page 1